Monocyte derived cells with immunosuppressive properties, process for their preparation and their uses in pharmaceutical compositions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 22, 2003
Grant Date -
N/A
app pub date -
Oct 2, 2000
filing date -
Mar 30, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Monocyte derived cells with immunosuppressive properties including an increase in at least one of the following PGE-2, IL-10 and IL-4. Monocyte derived cells with a decreased level of expression and secretion of inflammatory and immunostimulating cytokines and a decrease on the membrane of activation or accessory molecules in the presence of polylysine-cDNA in the nucleus of the monocyte derived cells.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully